Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Fred_Schwarzer
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
immunology
immuno-oncology |
| gptkbp:foundedYear |
2010
|
| gptkbp:founder |
gptkb:Fred_Schwarzer
|
| gptkbp:headquartersLocation |
gptkb:Mountain_View,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
IGM Biosciences, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
IGM-2323
IGM-8444 |
| gptkbp:numberOfEmployees |
over 200
|
| gptkbp:productType |
IgM antibody therapeutics
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:IGMS
|
| gptkbp:website |
https://www.igmbio.com/
|
| gptkbp:bfsParent |
gptkb:IGMS
|
| gptkbp:bfsLayer |
6
|